Home Biosimilar Antibodies Immunology & Inflammation Interleukins antibody Brazikumab (Anti-IL-23) For research use only.
Not for use in humans.

Brazikumab (Anti-IL-23)

Synonyms: AMG 139; MEDI2070

Brazikumab (Anti-IL-23) is a human IgG2 monoclonal antibody that selectively binds the p19 subunit of IL-23, with a KD of 0.138 nM for human IL-23. Brazikumab can be used for research on Crohn's disease. MW: 144.82 KD.

Brazikumab (Anti-IL-23)

Purity & Quality Control

Batch: A296501 Purity: 99% Protein concentration: 3.6mg/ml Endotoxin Level: ＜1EU/mg
99

Choose Selective Interleukins Inhibitors

Biological Activity

Description Brazikumab (Anti-IL-23) is a human IgG2 monoclonal antibody that selectively binds the p19 subunit of IL-23, with a KD of 0.138 nM for human IL-23. Brazikumab can be used for research on Crohn's disease. MW: 144.82 KD.

Product Details

CAS No. 1610353-18-8
Molecular Weight 144.82
Isotype Human IgG2SA
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Brazikumab (Anti-IL-23) | Brazikumab (Anti-IL-23) supplier | purchase Brazikumab (Anti-IL-23) | Brazikumab (Anti-IL-23) cost | Brazikumab (Anti-IL-23) manufacturer | order Brazikumab (Anti-IL-23) | Brazikumab (Anti-IL-23) distributor